Postoperative mechanical circulatory support with Biomedicus centrifugal pump

Asian Cardiovasc Thorac Ann. 2005 Mar;13(1):38-41. doi: 10.1177/021849230501300109.

Abstract

Despite advances in surgical techniques, myocardial protection, and management protocols, approximately 1% of patients undergoing open heart operations still need mechanical circulatory support for severe cardiac dysfunction. The Biomedicus centrifugal pump, available in most cardiovascular centers, is a highly effective and relatively inexpensive system compared to other more sophisticated devices for the same purpose. Of 10 patients aged 5 to 61 years who were supported for 22 to 168 hours with a Biomedicus centrifugal pump, 7 (70%) were weaned from support, there was one hospital death, and 6 patients were discharged from hospital. Two sudden deaths occurred in the first 8 months after discharge. Four patients (40%) were still alive after follow-up of 11-55 months, with no restriction in their daily activities. The centrifugal pump is a very cost-effective support system with survival rates comparable to those of more sophisticated devices in short-term ventricular assistance.

MeSH terms

  • Adolescent
  • Adult
  • Assisted Circulation / instrumentation*
  • Cardiac Surgical Procedures*
  • Cardiopulmonary Bypass
  • Centrifugation
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Postoperative Care / instrumentation*
  • Time Factors
  • Treatment Outcome